Navigation Links
Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
Date:4/24/2009

, which is currently in a phase 1 clinical trial for the treatment of patients with solid tumors. The Company's third clinical stage antibody is adecatumumab, also known as MT201, a traditional human monoclonal antibody that targets EpCAM-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet licensed a fourth clinical stage antibody, MT293, to TRACON Pharmaceuticals, Inc. MT293 is being developed in a phase 1 clinical trial for the treatment of patients with cancer. The Company's preclinical programs include MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis. Micromet has granted an exclusive option to Bayer Schering Pharma AG to license a BiTE antibody against an undisclosed solid tumor target. Additional BiTE antibodies, targeting CEA, CD33, Her2, EGFR and MCSP, respectively, are in different stages of preclinical development.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy, safety and intended utilization of blinatumomab, MT110, and its EGFR BiTE antibody. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or o
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
2. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
3. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
4. Micromet Key Events for 2009
5. Micromet Expands Committed Equity Financing Facility to $75 Million
6. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
7. Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
8. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
9. Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results
10. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
11. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  Image Stream Medical, ... new agreement with MedAssets, one of the largest group ... the United States.  Under terms of the three-year agreement, ... and services will be made available to MedAssets members ... the partnership, Image Stream Medical CEO Eddie Mitchell ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... addition of the "Clinical Laboratory,Molecular Diagnostics and ... to 2019 - Latin America, Africa and Middle ... A market that just keeps on growing. ... from the explosion in biotechnology, especially genomics. A ...
(Date:5/5/2015)... 5, 2015  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... months ended March 31, 2015 and reaffirmed its revenue, ... 2015. First Quarter 2015 Highlights Include: ... of 72% as compared to $10.9 million for the ... non-GAAP EBITDA of $11.5 million, an increase of 170% as ...
Breaking Medicine Technology:Image Stream Medical Announces Agreement with MedAssets 2Latin America, Africa and Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 3ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 5ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 6ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 7ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 8ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 9
... WIRE)--Apr 19, 2007 - Abraxis BioScience,Inc. ... first-time data from a pre-clinical study,evaluating ... nab-rapamycin,(ABI-009), an albumin-bound mTOR kinase inhibitor, ... Research (AACR) Annual Meeting held,April 14-18, ...
... Well Tolerated in Phase 2b Bladder Cancer Study, ... Inc., today announced results of a Phase,2b study ... of preclinical data of SPI (IRL)-1620 and satraplatin,at ... Cancer,Research, held at the Los Angeles Convention Center ...
Cached Medicine Technology:Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 2Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 3Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8
(Date:5/5/2015)... The newly minted Regan Arts has just released a unique self-help ... from his 20 years working in the field of wilderness therapy. ... a parenting book and why this one, she replied, “What resonates ... it is a journey, not a destination...that the question is not ... together and sometimes not...that each of our struggles is unique. What ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Skedans ... of Victoria BC announced the Skedans Sensor Collaboration Platform ... for mobile and web app developers, provides tooling to ... and mobile sensors. , The Skedans Sensor Collaboration Platform ... intersection of the Internet of Things, Web Real Time ...
(Date:5/5/2015)... 05, 2015 Information Innovators ... serving the federal government, today announced its acquisition ... CCSi provides solutions exclusively to federal government customers ... in cyber security, health services, and program management ... industry-relevant credentials as a Third Party Assessment Organization ...
(Date:5/5/2015)... On May, 5, 2015, My Positive Perspective ... Rose about alternatives for youngsters to do this summer. As ... the idea for starting a summer camp and how is ... company called Once Upon a Party and I come to ... and even scripture. We play games, sing, and dance and ...
(Date:5/5/2015)... 05, 2015 RF Technologies®, a leading ... Sensatec® ST750 Fall Management Solution with Voice Alarms. The ... patient or resident to wait for assistance when it ... the choice of 16 different melodies or tones or ... system such as Code Alert®. , For 28 ...
Breaking Medicine News(10 mins):Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3
... ZMH ; SWX: ZMH) announced today it will ... Conference in Key Biscayne,Florida, on April 30, 2008, at ... the presentation can be accessed via Zimmer,s,Investor Relations website ... replay following the conference., About the Company, ...
... Bill Which Includes Grants to,Train Realtime Captioners Who Meet ... VIENNA, Va., April 21 The National Court,Reporters Association ... of the House Subcommittee on Higher Education, Lifelong Learning ... to approve the,College Opportunity and Affordability Act of 2007 ...
... the Importance of Oral ... Health to Overall ... Concordia today unveiled the Smile for Health(R) Dental Health,Center on ... charge of their oral health. Informative dental health,brochures, articles and ...
... paper market, BENSENVILLE, Ill., April 21 ... paper, complies,with federal guidelines for paper-based security in ... the federal mandate,for tamper-resistant prescription pads, papers must ... prescription papers must meet all three,criteria by October ...
... Great Lakes,National Program Manager and Regional Administrator Mary A. ... and Lyman Welch of the Alliance for the Great ... to urge Chicagoans to,participate in EPA,s Great Lakes Earth ... million pounds of electronics or "e-waste" and 1 million,pills ...
... Older Americans are quite satisfied, while Baby Boomers are the ... -- With age comes wisdom, and now new research suggests ... taken since 1972 suggest that plenty of older people are ... women over the age of 80 saying they,re "very happy," ...
Cached Medicine News:Health News:NCRA Urges Congressman David Wu to Approve in Conference the Higher Education Reauthorization Bill Providing Closed Captioning for 30 Million Deaf and Hard-of-Hearing Americans 2Health News:United Concordia Launches New Online Dental Health Center 2Health News:Boise(R) BEWARE(R) Meets April 1 Federal Medicaid Guidelines Requiring Tamper-Resistant Prescription Paper 2Health News:Boise(R) BEWARE(R) Meets April 1 Federal Medicaid Guidelines Requiring Tamper-Resistant Prescription Paper 3Health News:EPA's Earth Day Challenge: Collect 1 Million Pills and 1 Million Pounds of E-Waste to Help Protect the Great Lakes 2Health News:Seniors No Strangers to Happiness 2Health News:Seniors No Strangers to Happiness 3
... Craftsmanship have produced the finest ... Ocutek now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Craftsmanship have produced the finest ... Ocutek now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: